ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Linking disease severity and mortality in obstructive sleep apnea: the role of the endothelial activation and stress index.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundSystemic inflammation and endothelial dysfunction are implicated in adverse outcomes in obstructive sleep apnea (OSA), yet accessible biomarkers linking disease severity with long-term risk remain limited. The Endothelial Activation and Stress Index (EASIX) has been associated with mortality in various settings, but its role in OSA is unclear.
methodsWe analyzed data from 9,797 participants in the National Health and Nutrition Examination Survey (NHANES) to investigate the association between EASIX and all-cause and cardiovascular mortality using weighted Cox regression and restricted cubic spline models. Machine learning models were further developed to assess predictive performance and interpret feature importance using SHAP. In addition, a hospital-based cross-sectional clinical dataset (n = 258) was used to examine the relationship between EASIX and OSA severity indices, including the apnea-hypopnea index (AHI) and oxygen desaturation index (ODI).
resultsHigher EASIX levels were independently associated with increased risks of all-cause and cardiovascular mortality. Distinct dose-response patterns were observed, with a nonlinear association for all-cause mortality and a linear relationship for cardiovascular mortality. Machine learning models demonstrated strong predictive performance, with EASIX identified as a key contributor by SHAP analysis. In the clinical dataset, EASIX was significantly associated with both AHI and ODI, indicating a close relationship with OSA severity.
conclusionsEASIX is associated with both mortality and disease severity in OSA, suggesting its potential as a practical biomarker for risk stratification and integrated clinical assessment.
Indexed as
Identifiers
42704465What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.